BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21403462)

  • 41. [Multiple myeloma complicated with Takotsubo cardiomyopathy].
    Mitsumori T; Nakajima K; Nozaki Y; Hamanaka S; Nagashima T; Kirito K; Iwao N; Komatsu N
    Rinsho Ketsueki; 2010 Apr; 51(4):291-6. PubMed ID: 20467228
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
    Hoshino S; Saito H; Wada M; Akutsu M; Shiozaki H; Takanashi M; Takei Y; Tanaka S; Teramura M; Takada K
    Rinsho Ketsueki; 1987 Mar; 28(3):358-65. PubMed ID: 3475485
    [No Abstract]   [Full Text] [Related]  

  • 43. [Gross spreading multiple extramedullary plasmacytomas to the skin in the terminal stage of multiple myeloma].
    Kanno M; Nakamura S; Danno D; Uotani C; Kotani T; Yamanaka S; Terasaki Y; Matano S; Okumura H
    Rinsho Ketsueki; 2001 Jul; 42(7):554-8. PubMed ID: 11524846
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case of aggressive myeloma with abnormal plasmocytes in pleural effusion and cerebrospinal fluid].
    Sekikawa T; Iwase S; Kawano T; Takahara S; Ito K; Yamada J; Yamazaki Y; Yamada H
    Rinsho Ketsueki; 1999 Jan; 40(1):22-7. PubMed ID: 10067092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effects of bortezomib at different doses in combination with dexamethasone in treatment of relapsed or refractory multiple myeloma: a comparative study].
    Bao L; Lu XJ; Zhang XH; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1829-31. PubMed ID: 19040018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.
    Berenson JR; Yang HH; Vescio RA; Nassir Y; Mapes R; Lee SP; Wilson J; Yellin O; Morrison B; Hilger J; Swift R
    Ann Hematol; 2008 Aug; 87(8):623-31. PubMed ID: 18463870
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bortezomib plus melphalan and prednisone for multiple myeloma.
    Avvisati G
    N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090032
    [No Abstract]   [Full Text] [Related]  

  • 48. [Multiple myeloma -- therapy].
    Jung W; Zettl F; Schroers R
    Dtsch Med Wochenschr; 2005 Feb; 130(6):283-6; quiz 287-90. PubMed ID: 15692903
    [No Abstract]   [Full Text] [Related]  

  • 49. Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib.
    Gozzetti A; Cerase A; Tarantino A; Fabbri A; Bocchia M; Pirrotta MT; Lauria F
    Clin Lymphoma Myeloma; 2007 Mar; 7(5):376-8. PubMed ID: 17562250
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unusual discordant responses in two multiple myeloma patients during bortezomib treatment.
    Pirrotta MT; Gozzetti A; Cerase A; Bucalossi A; Bocchia M; Defina M; Lauria F
    Onkologie; 2008 Feb; 31(1-2):45-7. PubMed ID: 18268398
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis of multiple myeloma by demonstrating plasma cells in bronchoalveolar lavage].
    Burkhardt O; Dickgreber NJ; Bühling F; Waldburg N; Merker HJ; Welte T
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1951-4. PubMed ID: 14502447
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Autopsy case of light chain deposition disease presented by nephrotic syndrome].
    Suzuki S; Yokota S; Masuyama T; Ogihara H; Ohishi M; Katayama N; Koizumi H; Namiki M
    Nihon Jinzo Gakkai Shi; 2013; 55(1):63-70. PubMed ID: 23461212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [clinical study and physiopathology of multiple myeloma].
    Kuramoto A
    Nihon Naika Gakkai Zasshi; 1992 Sep; 81(9):1335-47. PubMed ID: 1453054
    [No Abstract]   [Full Text] [Related]  

  • 54. Anaplastic atypical myeloma with extensive cutaneous involvement in a dog.
    Fukumoto S; Hanazono K; Kawasaki N; Hori Y; Higuchi S; Sasaki T; Temma K; Uchide T
    J Vet Med Sci; 2012 Jan; 74(1):111-5. PubMed ID: 21873808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma cell leukemia: case report of a rare and aggressive variant of multiple myeloma.
    Jameel A
    J Pak Med Assoc; 2005 Oct; 55(10):452-3. PubMed ID: 16304856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multiple myeloma with coexistent myelofibrosis: improvement of myelofibrosis following recovery from multiple myeloma after treatment with melphalan and prednisolone.
    Kawauchi K; Mori H; Sugiyama H; Oshimi K; Hirayama A
    Jpn J Med; 1991; 30(5):483-6. PubMed ID: 1803051
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A case of multiple myeloma with infiltration into skeletal muscle after injections of a granulocyte-colony stimulating-factor].
    Kikuchi M; Inagaki T; Ueda R
    Nihon Ronen Igakkai Zasshi; 2002 Jul; 39(4):433-8. PubMed ID: 12187809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A feline case of multiple myeloma treated with bortezomib.
    Tani H; Miyamoto R; Miyazaki T; Oniki S; Tamura K; Bonkobara M
    BMC Vet Res; 2022 Nov; 18(1):384. PubMed ID: 36324112
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Plasmacytoma with multiple hypervascular lesions revealed by angiography in a patient with multiple myeloma].
    Handa H; Irisawa H; Komatsumoto S; Matsushima T; Tsukamoto N; Nojima Y; Murakami H
    Rinsho Ketsueki; 2006 Jun; 47(6):521-5. PubMed ID: 16862980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid myopathy and myeloma: response to treatment.
    Sheehan-Dare RA; Simmons AV
    Postgrad Med J; 1987 Feb; 63(736):141-2. PubMed ID: 3671242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.